Clinical commissioning of the first point-of-care spectral photon-counting CT for the upper extremities.

BACKGROUND: Acceptance testing and quality assurance (QA) of computed tomography (CT) scans are of great importance to ensure the appropriate performance of the systems. However, current standards and guidelines do not include a dedicated QA program for spectral photon-counting CT (SPCCT), nor adapted tolerance levels. PURPOSE: To evaluate the technical performance, in terms of image quality and radiation dose, of the first point-of-care SPCCT for the upper extremities (MARS Extremity 5X120, MARS Bioimaging Ltd., Christchurch, New Zealand) and to establish a comprehensive QA program. METHODS: The specific dimensions of the scanner with a 125 mm diameter gantry and a small voxel size of 0.1 × 0.1 × 0.1 mm3 require the use of suitable phantoms and evaluation techniques. Indicators such as CT number accuracy, image noise, uniformity, and slice thickness were assessed to characterize the image quality. The in-plane and longitudinal spatial resolutions were evaluated by means of the modulation transfer function (MTF). Noise power spectra (NPS) were calculated to further evaluate the image noise. Material identification capabilities were assessed using clinically relevant high-Z materials (iodine, gold, gadolinium, and calcium). A 100-mm diameter CTDI-like phantom was used to measure the dose indices. A complete radiation survey was carried out to measure the radiation exposure at different points around the scanner. RESULTS: The proposed QA program is based on international and local recommendations as well as practical experience. It includes standardised CT tests and SPCCT-specific methods. Additional methodologies to further assess the system performance are also presented. Tolerance levels are discussed and revised when appropriate. Both in-plane and longitudinal high spatial resolutions were evidenced by the MTF measurements with 1.8 lp· mm-1 and 5.0 lp· mm-1 at 10%, respectively. The calculated effective slice thickness ranged between 0.15 and 0.16 mm for the five energy bins and for a reconstructed voxel size of 0.1 × 0.1 × 0.1 mm3 . Reference values of the linear attenuation coefficient of water have been calculated and used to assess the CT number uniformity of water. Evaluation of the CT number accuracy and stability of various clinically relevant materials showed excellent spectral correlation and linearity between HU values and concentrations (r2 > 0.99). The NPS showed less noise correlation between slices than within transverse slice, as well as a systematic increase at low spatial frequencies. The volume CT dose index (CTDI v o l $_{vol}$ ) for a custom-made 100 mm diameter phantom was 9.32 mGy. Radiation measurements around the scanner showed that it is completely shielded except for the access port, and that no additional protective measures are necessary for the patient. CONCLUSIONS: A routine QA framework for SPCCT systems has been proposed. Image quality and radiation dose were assessed using newly designed phantoms, relevant metrics, and automated algorithms. Baseline values were established and tolerance levels discussed for the MARS SPCCT scanner based on collected data and international recommendations.

Efficiency of the RADPAD Surgical Cap in Reducing Brain Exposure During Pacemaker and Defibrillator Implantation.

OBJECTIVES: This study sought to investigate the RADPAD No Brainer (Worldwide Innovation and Technologies, Overland Park, Kansas) efficiency in reducing brain exposure to scattered radiation. BACKGROUND: Cranial radioprotective caps such as the RADPAD No Brainer are being marketed as devices that significantly reduce operator's brain exposure to scattered radiation. However, the efficiency of the RADPAD No Brainer in reducing brain exposure in clinical practice remains unknown to date. METHODS: Five electrophysiologists performing device implantations over a 2-month period wore the RADPAD cap with 2 strips of 11 thermoluminescent dosimeter pellets covering the front head above and under the shielded cap. Phantom measurements and Monte Carlo simulations were performed to further investigate brain dose distribution. RESULTS: Our study showed that the right half of the operators' front head was the most exposed region during left subpectoral device implantation; the RADPAD cap attenuated the skin front-head exposure but provided no protection to the brain. The exposure of the anterior part of the brain was decreased by a factor of 4.5 compared with the front-head skin value thanks to the skull. The RADPAD cap worn as a protruding horizontal plane, however, reduced brain exposure by a factor of 1.7 (interquartile range: 1.3 to 1.9). CONCLUSIONS: During device implantation, the RADPAD No Brainer decreased the skin front head exposure but had no impact on brain dose distribution. The RADPAD No Brainer worn as a horizontal plane worn around the neck reduces brain exposure and confirms that the exposure comes from upward scattered radiation.

Eye lens monitoring programme for medical staff involved in fluoroscopy guided interventional procedures in Switzerland.

Epidemiological studies indicate that radiation damages to the eye lens occurs at lower dose values than previously considered (Worgul et al., 2007; Chodick et al., 2008; Ciraj-Bjelac et al., 2010; Rehani et al., 2011; Vano et al., 2010) [1-5]. The International Commission on Radiological Protection lowered the equivalent dose limit value for the eye lens to 20 mSv/year (ICRP, n.d.) [6]. This new limit has been incorporated into the revised Swiss legislation [7]. Prior this change, it was agreed that if the effective dose limit was respected it would implicitly imply the respect of the limit to the eye lens, for penetrating radiation. The concept had to be reviewed in the light of necessary application of the new eye lens dose limit. The new Swiss legislation proposes to use the value of Hp(0.07) measured over the protective apron to estimate the eye lens dose. This study aims to investigate the validity of this approach for medical staff during fluoroscopy guided procedures. The results show that the ratio between thorax and eye lens doses varies greatly from one medical speciality to another, but also between surgeons within the same speciality. Moreover, for a given physician, the ratio varied over the periods of surveillance. Those variations confirmed the crucial influence of external parameters related to experience, practice and workload. The surveillance method is appropriate for most of the procedures performed in the department included in this study. Nevertheless, for the particular configuration in urology, the respect of the effective dose limit measured by the routine dosimetry does not allow direct compliance with the dose limit to the eye lens, unless appropriate protective eye wear gear are worn.

Dosimetry in MARS spectral CT: TOPAS Monte Carlo simulations and ion chamber measurements.

Spectral computed tomography (CT) is an up and coming imaging modality which shows great promise in revealing unique diagnostic information. Because this imaging modality is based on X-ray CT, it is of utmost importance to study the radiation dose aspects of its use. This study reports on the implementation and evaluation of a Monte Carlo simulation tool using TOPAS for estimating dose in a pre-clinical spectral CT scanner known as the MARS scanner. Simulated estimates were compared with measurements from an ionization chamber. For a typical MARS scan, TOPAS estimated for a 30 mm diameter cylindrical phantom a CT dose index (CTDI) of 29.7 mGy; CTDI was measured by ion chamber to within 3% of TOPAS estimates. Although further development is required, our investigation of TOPAS for estimating MARS scan dosimetry has shown its potential for further study of spectral scanning protocols and dose to scanned objects.

Radiation exposure using the O-arm® surgical imaging system.

PURPOSE: This study was conducted to characterise the O-arm® surgical imaging system in terms of patient organ doses and medical staff occupational exposure during three-dimensional thoracic spine and pelvic examinations. METHODS: An anthropomorphic phantom was used to evaluate absorbed organ doses during a three-dimensional thoracic spine scan and a three-dimensional pelvic scan with the O-arm®. Staff occupational exposure was evaluated by constructing an ambient dose cartography of the operating theatre during a three-dimensional pelvic scan as well as using an anthropomorphic phantom to simulate the O-arm® operator. RESULTS: Patient organ doses ranged from 30 ± 4 µGy to 20.0 ± 3.0 mGy and 4 ± 1 µGy to 6.7 ± 1.0 mGy for a three-dimensional thoracic spine and pelvic examination, respectively. For a single three-dimensional acquisition, the maximum ambient equivalent dose at 2 m from the iso-centre was 11 ± 1 µSv. CONCLUSION: Doses delivered to the patient during a three-dimensional thoracic spine image acquisition were found to be significant with the O-arm®, but lower than those observed with a standard computed tomography examination. The detailed dose cartography allows for the optimisation of medical staff positioning within the operating theatre while imaging with the O-arm®.

The value of protective head cap and glasses in neurointerventional radiology.

BACKGROUND: Protection of the head and eyes of the neurointerventional radiologist is a growing concern, especially after recent reports on the incidence of brain cancer among these personnel, and the revision of dose limits to the eye lens. The goal of this study was to determine typical occupational dose levels and to evaluate the efficiency of non-routine radiation protective gear (protective eyewear and cap). Experimental correlations between the dosimetric records of each measurement point and kerma area product (KAP), and between whole body doses and eye lens doses were investigated. METHODS: Measurements were taken using thermoluminescent dosimeters placed in plastic bags and worn by the staff at different places. To evaluate the effective dose, whole body dosimeters (over and under the lead apron) were used. RESULTS: The mean annual effective dose was estimated at 0.4 mSv. Annual eye lens exposure was estimated at 17 mSv when using a ceiling shield but without protective glasses. The protective glasses reduced the eye lens dose by a factor of 2.73. The mean annual dose to the brain was 12 mSv; no major reduction was observed when using the cap. The higher correlation coefficients with KAP were found for the dosimeters positioned between the eyes (R(2)=0.84) and above the apron, and between the eye lens (R(2)=0.85) and the whole body. CONCLUSIONS: Under the specific conditions of this study, the limits currently applicable were respected. If a new eye lens dose limit is introduced, our results indicate it could be difficult to comply with, without introducing additional protective eyewear.